Damodaran Chendil, Ph.D.
Assistant Professor
Center of Excellence in Reproductive Sciences
Dr. Chendil has a Doctorate in Cancer Biology from the University of Madras. He is an Assistant Professor in the Center of Excellence in Reproductive Sciences.
Research Focus
The identification of novel phytochemicals that are chemopreventive and/or chemotherapeutic with respect to prostate and breast cancer. As an extension of the breast and prostate cancer research efforts, Dr. Chendil is involved in synthesizing and testing the derivatives of the bioactive parent compounds detailed above; some compounds appear to be more effective than their parent compounds. Dr. Chendil’s pursuit of drugs for cancer therapy from natural products contributes significantly identifying new drugs that might possibly cure cancer or prevent its occurrence. Currently, funding sources that support this research program include the National Institutes of Health, Komen Breast Cancer Foundation, Kentucky Lung Cancer Research Program, and American Cancer Society.
For Dr. Chendil's laboratory website, click here.
Recent Publications
Srinivasan Sowmyalakshmi, Rama. S Ranga, Ravshan Burikhanov, and Chendil D., Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells. (2007) Cancer Res; 67; (1). January 1, 2007.
Rohini Gomathinayagam and Chendil Damodaran. The radiosensitization effect of 2-deoxy-D-Glucose on Human Glimoa cells. (2006) Cancer Biol Ther. 2006 Sep;5(9):1152-3.
Rama, S Ranga, Srinivasan Sowmyalakshmi, Ravshan Burikhanov, Mohammed A. Akbarsha and Chendil D., A herbal medicine for the treatment for lung cancer. (2005) Mol Cell Biochem Dec;280(1-2):125-33
|
COLLEGE OF
Health Sciences
Equal Opportunity University